Cas:802590-64-3 unii-116eyz0ppx manufacturer & supplier

Chemical Name:unii-116eyz0ppx

CAS.NO:802590-64-3

Synonyms:Bis[1,3,5,2,4]trioxadiphosphepino[6,7-g:6′,7′-i]-1,3,5,2,4-benzotrioxadiphosphepin, hexahydro-2,4,7,9,12,14-hexahydroxy-, 2,4,7,9,12,14-hexaoxide;Myo-inositol trispyrophosphate;UNII-116EYZ0PPX component HEDKSUBRULAYNO-CNWJWELYSA-N;Hexahydrobis[1,3,5,2,4]trioxadiphosphepino[6,7-g:6′,7′-i][1,3,5,2,4]benzotrioxadiphosphepine-2,4,7,9,12,14-hexol 2,4,7,9,12,14-hexaoxide

Molecular Formula:C₆H₁₂O₂₁P₆

Molecular Weight:605.990

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:862.3±75.0 °C at 760 mmHg

Density:2.4±0.1 g/cm3

Index of Refraction:1.609

PSA:365.73000

Exact Mass:605.829651

LogP:0.00420

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Bis[1,3,5,2,4]trioxadiphosphepino[6,7-g:6′,7′-i]-1,3,5,2,4-benzotrioxadiphosphepin, hexahydro-2,4,7,9,12,14-hexahydroxy-, 2,4,7,9,12,14-hexaoxide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Hexahydrobis[1,3,5,2,4]trioxadiphosphepino[6,7-g:6′,7′-i][1,3,5,2,4]benzotrioxadiphosphepine-2,4,7,9,12,14-hexol 2,4,7,9,12,14-hexaoxide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,UNII-116EYZ0PPX component HEDKSUBRULAYNO-CNWJWELYSA-N Use and application,Bis[1,3,5,2,4]trioxadiphosphepino[6,7-g:6′,7′-i]-1,3,5,2,4-benzotrioxadiphosphepin, hexahydro-2,4,7,9,12,14-hexahydroxy-, 2,4,7,9,12,14-hexaoxide technical grade,usp/ep/jp grade.

Related News: Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS. unii-116eyz0ppx manufacturer Novak noted that the research team did see some improvement in standard brain function tests given to a smaller group of trial participants who had actually been diagnosed with Alzheimer’s. unii-116eyz0ppx supplier Novak noted that the research team did see some improvement in standard brain function tests given to a smaller group of trial participants who had actually been diagnosed with Alzheimer’s. unii-116eyz0ppx vendor Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as bulk pharmaceutical chemicals (BPCs). unii-116eyz0ppx factory The move follows a Class I recall, the FDA’s most serious, launched by Innova in late April amid “significant concerns” about the test’s accuracy—and alongside an official warning letter delivered to the company this week.